Tags: immunotherapy

9/12/2018

Reuters story on kidney cancer drug makes us ask: How is this journalism?

4/17/2018

Immunotherapy prolongs survival, but at what cost? Washington Post needed more on treatment downsides

4/17/2018

Without any independent sources providing insight, readers of TIME’s coverage on lung cancer immunotherapy mostly left in the dark

10/24/2017

Washington Post wisely quantifies severe side effects and deaths from CAR-T cell therapy

9/21/2017

AP’s story on cancer immunotherapy quickly mentions low success rate

7/18/2017

Washington Post wisely notes that CAR T-cell therapy may cost at least $300,000

7/13/2017

It’s misleading to call results from phase 1 trials with 6 and 13 patients a ‘cancer breakthrough’

6/1/2017

Immunotherapy’s ‘new era:’ LA Times story overlooks the risks and overstates trial results

5/22/2017

Keytruda for bladder cancer: No independent scrutiny of Merck-reported results

4/4/2017

‘Promising’ new lymphoma treatment gets superficial, one-sided coverage by CBS

Story Reviews

Systematic, Criteria-Driven

@HealthNewsRevu

Retweet on Twitter HealthNewsReview.org Retweeted

Alan Cassels @AKECassels·

Puleeeeease... this 'game changer' weight loss drug causes more nausea and vomiting than a placebo. Some game, some change. My friend Gary would spank you for using the eighth word medical reporters should never, ever use. @garyschwitzer @thackerpd
https://www.healthnewsreview.org/toolkit/just-journalists-writing-tips-case-studies/7-words-and-more-you-shouldnt-use-in-medical-news/ https://twitter.com/OttawaCitizen/status/1361426796126830597

Reply on Twitter 1361431489326407680 Retweet on Twitter 13614314893264076806 Like on Twitter 13614314893264076808 Twitter 1361431489326407680

Retweet on Twitter HealthNewsReview.org Retweeted

RxISK @RxISK·

A scary @statnews Op-Ed warns that govt attempts to rein in Pharma may cut off access to "life-changing" drugs.

It takes @garyschwitzer to let us know: the author spent 10 years as Pfizer's public-policy chief. https://twitter.com/garyschwitzer/status/1360325022578053123

Reply on Twitter 1361420459284131843 Retweet on Twitter 13614204592841318439 Like on Twitter 136142045928413184319 Twitter 1361420459284131843

HealthNewsReview.org @HealthNewsRevu·

.@TranspariMED criticizes STAT op-ed for not disclosing pharma funding of author’s institute - similar to criticism we’ve made of STAT op-eds in the past. @transparify @ThinkTankWatch @icer_review https://www.healthnewsreview.org/2021/02/transparency-watchdog-criticizes-stats-non-disclosure-on-pro-pharma-op-ed/

Reply on Twitter 1360214949704982532 Retweet on Twitter 13602149497049825325 Like on Twitter 136021494970498253210 Twitter 1360214949704982532